Compare Assays lab reagents for research




Suppliers for Lab reagents


NATtrol Human Parvovirus B19 (10,000 IU/mL) (1 mL)

NATPARVO-0001 Zeptometrix 1 mL

NATtrol Human Parvovirus B19 (100,000 IU/mL) (1 mL)

NATPARVO-0002 Zeptometrix 1 mL

NATtrol Human Parvovirus B19 (1,000,000 IU/mL) (1 mL)

NATPARVO-0003 Zeptometrix 1 mL

NATtrol Human Parvovirus B19 (10,000,000 IU/mL) (1 mL)

NATPARVO-0004 Zeptometrix 1 mL

NATtrol Human Parvovirus B19 (100,000,000 IU/mL) (1 mL)

NATPARVO-0005 Zeptometrix 1 mL

NATtrol Adenovirus Type 40 (Stool Matrix) (0.5 mL)

NATADV40-GP Zeptometrix 0.5 mL

NATtrol Adenovirus Type 41 (Stool Matrix) (0.5 mL)

NATADV41-GP Zeptometrix 0.5 mL


Polyclonal ETO polyclonal antibody

APR00372G Leading Biology 0.05ml 580.8 EUR

Polyclonal SHH Polyclonal Antibody

APR00434G Leading Biology 0.1mg 580.8 EUR

Polyclonal ETO polyclonal antibody

APR00435G Leading Biology 0.1ml 633.6 EUR

Polyclonal p53 polyclonal antibody

APR00443G Leading Biology 0.05mg 633.6 EUR

Polyclonal G9a polyclonal antibody

APR00448G Leading Biology 0.1ml 580.8 EUR

Polyclonal PML polyclonal antibody

AMR09397G Leading Biology 0.05mg 580.8 EUR

Polyclonal YY1 polyclonal antibody

APR14018G Leading Biology 0.1ml 580.8 EUR

Polyclonal RARA polyclonal antibody

APR00370G Leading Biology 0.05ml 580.8 EUR


Our used monoclonals in Pubmed.

Dermatophyte Test Medium (DTM Test Agar) (Powder)

MBS653290-5x500g MyBiosource 5x500g 1645 EUR

Test Product

ZX001 AAT Bioquest 1mg Ask for price

Test Product

ZX002 AAT Bioquest 5mg Ask for price

Test product

testttt National Diagnostics 0 Ask for price

LISTERIA TEST

AKE0007 Diatheva 96 TEST-1 PLATE 795.7 EUR



Compare monoclonal lab reagents for research




Suppliers for Lab Assays


BV-MR-LBD. Recombinant baculovirus expressing Mineralocorticoid receptor LBD.

S27 AB Vector LLC 1 ml
Description: Drug discovery, Nuclear receptors, baculovirus

MR-LBD. Purified GST-tagged MR LBD in complex with Hsp90. Applications: Ligand-binding and coregulator displacement assays.

S28 AB Vector LLC 50 ug
Description: Drug discovery, Nuclear receptors, purified recombinant protein

BV-GR-LBD. Recombinant baculovirus expressing Glucocorticoid receptor LBD.

S33 AB Vector LLC 1 ml
Description: Drug discovery, Nuclear receptors, baculovirus

BV-GR. Recombinant baculovirus expressing Glucocorticoid receptor.

S35 AB Vector LLC 1 ml
Description: Drug discovery, Nuclear receptors, baculovirus

BV-PXR-LBD. Recombinant baculovirus expressing Pregnane X receptor LBD.

S36 AB Vector LLC 1 ml
Description: Drug discovery, Nuclear receptors, baculovirus

BV-AhR. Recombinant baculovirus expressing Aryl hydrocarbon receptor LBD.

S41 AB Vector LLC 1 ml
Description: Drug discovery, Nuclear receptors, baculovirus

AhR-LBD. Purified GST-tagged human Arylhydrocarbon receptor LBD in complex with Hsp90. Applications: Ligand-binding and coregulator displacement assays.

SAh90 AB Vector LLC 50 ug
Description: Drug discovery, Nuclear receptors, purified recombinant protein


Polyclonal ETO polyclonal antibody

APR00372G Leading Biology 0.05ml 580.8 EUR

Polyclonal SHH Polyclonal Antibody

APR00434G Leading Biology 0.1mg 580.8 EUR

Polyclonal ETO polyclonal antibody

APR00435G Leading Biology 0.1ml 633.6 EUR

Polyclonal p53 polyclonal antibody

APR00443G Leading Biology 0.05mg 633.6 EUR

Polyclonal G9a polyclonal antibody

APR00448G Leading Biology 0.1ml 580.8 EUR

Polyclonal PML polyclonal antibody

AMR09397G Leading Biology 0.05mg 580.8 EUR

Polyclonal YY1 polyclonal antibody

APR14018G Leading Biology 0.1ml 580.8 EUR

Polyclonal RARA polyclonal antibody

APR00370G Leading Biology 0.05ml 580.8 EUR


Our used References in Pubmed.

CTAG2 Recombinant Protein (Mouse) (Recombinant-P Tag)

RP126446 ABM 100 ug Ask for price

S. aureus Recombinant Protein A Recombinant Protein

PROTB3GGB2 BosterBio 20ug 243 EUR

TWEAK, recombinant / TNFSF12, recombinant (Human) - ELISA Kit

EK-054-85 PHOENIX PEPTIDE 96 wells 660.96 EUR

Mouse Recombinant anti-Rat CD3 Recombinant Antibody

xAP-0878 Angio Proteomie 100ug 280 EUR

Rat Recombinant anti-Mouse CD25 Recombinant Antibody

xAP-0593 Angio Proteomie 100ug 280 EUR



Compare polyclonal lab reagents for research




Suppliers for Lab reagents


Recombinant RNA-directed RNA polymerase L (L)

MBS1147877-002mgYeast MyBiosource 0.02mg(Yeast)

Recombinant RNA-directed RNA polymerase L (L)

MBS1147877-01mgEColi MyBiosource 0.1mg(E-Coli)

Recombinant RNA-directed RNA polymerase L (L)

MBS1147877-01mgYeast MyBiosource 0.1mg(Yeast)

RNA Storage

E0308-01 EURx 10x1.5ml

RNA-directed RNA polymerase beta chain Antibody

MBS7153538-INQUIRE MyBiosource INQUIRE

RNA-directed RNA polymerase beta chain Antibody

MBS7162494-INQUIRE MyBiosource INQUIRE

RNA-directed RNA polymerase beta chain Antibody

MBS7164695-INQUIRE MyBiosource INQUIRE


Recombinant Humanp21 Recombinant Protein

92-035 ProSci 0.05 mg 821.4 EUR

TWEAK, recombinant / TNFSF12, recombinant (Human)

054-85 PHOENIX PEPTIDE 10 μg 261.36 EUR

TAGLN Recombinant Protein (Rat) (Recombinant- Tag)

RP232205 ABM 100 ug Ask for price

TAGLN2 Recombinant Protein (Rat) (Recombinant Tag)

RP232208 ABM 100 ug Ask for price

TAGLN3 Recombinant Protein (Rat) (Recombinant Tag)

RP232211 ABM 100 ug Ask for price

TAGLN3 Recombinant Protein (Rat) (Recombinant Tag)

RP232214 ABM 100 ug Ask for price

TAGAP Recombinant Protein (Human) (Recombinant- Tag)

RP030880 ABM 100 ug Ask for price

TAGLN Recombinant Protein (Human) (Recombinant- Tag)

RP030883 ABM 100 ug Ask for price


Our used recombinants in Pubmed.

Anti- GPR162 Antibody Antibody

GWB-AAD3BE GenWay Biotech 0.05 ml Ask for price

Anti- GPR162 Antibody Antibody

GWB-C5010A GenWay Biotech 0.05 ml Ask for price

Anti-CD31 Antibody Antibody

MBS8304163-003mL MyBiosource 0.03mL 185 EUR

Anti-CD31 Antibody Antibody

MBS8304163-01mL MyBiosource 0.1mL 255 EUR

Anti-CD31 Antibody Antibody

MBS8304163-02mL MyBiosource 0.2mL 335 EUR



Compare polyclonal lab reagents for research






Suppliers for Lab ELISAs


HIV-1 gp120

V7074 Antagene 0.2mg

HIV-1 gp120

GWB-439A1B GenWay Biotech 0.1 mg

HIV-2 gp160

hiv-013 ProSpec Tany 100µg
Description: Recombinant HIV-2 gp160

HIV-1 gp120

hiv-102 ProSpec Tany 100µg
Description: Recombinant HIV-1 gp120 nef Mosaic

HIV-1 p1724

hiv-121 ProSpec Tany 100µg
Description: Recombinant HIV-1 gag p17, p24

HIV-1 gp120

GWB-696AF8 GenWay Biotech 0.1 mg

HIV-2 env.gp36

GWB-778C9B GenWay Biotech 1 mg


REC-1

ABC-TC0956 AcceGen 1 vial Ask for price

pGADT7-Rec

PVTY00072 Nova Lifetech 2ug 280 EUR

pGADT7-Rec

PVT4025 Nova Lifetech 2ug 216 EUR

REC-2615 (HCl)

530142 MedKoo Biosciences 10.0mg 295 EUR

Rec FLA-ST

tlrl-flic-10 InvivoGen FR 10 µg 295.05 EUR

Rec FLA-ST

tlrl-flic-50 InvivoGen FR 50 µg 731.85 EUR

rec EGF (human)

4030572.01 Bachem 0.1 mg 102.27 EUR

rec EGF (human)

4030572.05 Bachem 0.5 mg 271.85 EUR


Our used antibodies in Pubmed.

Polyclonal Hira polyclonal antibody

APR00449G Leading Biology 0.1ml 580.8 EUR

Polyclonal SPI1 polyclonal antibody

APR00451G Leading Biology 0.1ml 580.8 EUR

Polyclonal BMI1 polyclonal antibody

APR00457G Leading Biology 0.1ml 580.8 EUR

Polyclonal CHD4 polyclonal antibody

APR00459G Leading Biology 0.05mg 580.8 EUR

Polyclonal Rtf1 polyclonal antibody

APR11187G Leading Biology 0.05mg 633.6 EUR



Assay Lab Reagents for Research



Promoted Lab rec.


Polyclonal ETO polyclonal antibody

APR00372G Leading Biology 0.05ml 580.8 EUR

Polyclonal SHH Polyclonal Antibody

APR00434G Leading Biology 0.1mg 580.8 EUR

Polyclonal ETO polyclonal antibody

APR00435G Leading Biology 0.1ml 633.6 EUR

Polyclonal p53 polyclonal antibody

APR00443G Leading Biology 0.05mg 633.6 EUR

Polyclonal G9a polyclonal antibody

APR00448G Leading Biology 0.1ml 580.8 EUR

Polyclonal PML polyclonal antibody

AMR09397G Leading Biology 0.05mg 580.8 EUR



Polyclonal ETO polyclonal antibody

APR00372G Leading Biology 0.05ml 580.8 EUR

Polyclonal SHH Polyclonal Antibody

APR00434G Leading Biology 0.1mg 580.8 EUR

Polyclonal ETO polyclonal antibody

APR00435G Leading Biology 0.1ml 633.6 EUR

Polyclonal p53 polyclonal antibody

APR00443G Leading Biology 0.05mg 633.6 EUR

Polyclonal G9a polyclonal antibody

APR00448G Leading Biology 0.1ml 580.8 EUR

Polyclonal PML polyclonal antibody

AMR09397G Leading Biology 0.05mg 580.8 EUR

Polyclonal YY1 polyclonal antibody

APR14018G Leading Biology 0.1ml 580.8 EUR


Our used antibodies in Pubmed.

pGADT7- Rec- 53

PVT11254 Nova Lifetech 2ug 260 EUR

rec Leptin (human)

4038283.02 Bachem 0.2 mg 102.27 EUR

rec Leptin (human)

4038283.1 Bachem 1 mg 271.85 EUR

rec Leptin (mouse)

4038284.02 Bachem 0.2 mg 102.27 EUR

rec Leptin (mouse)

4038284.1 Bachem 1 mg 271.85 EUR

rec Leptin (human)

H-5578.0200 Bachem 0.2mg 194.4 EUR

rec Leptin (human)

H-5578.1000 Bachem 1.0mg 457.2 EUR

rec Leptin (mouse)

H-5582.0200 Bachem 0.2mg 194.4 EUR

rec Leptin (mouse)

H-5582.1000 Bachem 1.0mg 457.2 EUR

Rec-KPC protein

MBS313821-01mg MyBiosource 0.1mg 860 EUR


A Complex Life Habitable Zone Based On Lipid Solubility Theory

A Complex Life Habitable Zone Based On Lipid Solubility Theory

To discover doubtlessly liveable exoplanets, area missions make use of the liveable zone (HZ), which is the area round a star (or a number of stars) the place standing our bodies of water might exist on the floor of a rocky planet. Follow-up atmospheric characterization might yield biosignatures signifying life.

A Complex Life Habitable Zone Based On Lipid Solubility Theory
A Complex Life Habitable Zone Based On Lipid Solubility Theory

Although most iterations of the HZ are agnostic relating to the character of such life, a latest research argues {that a} advanced life HZ could be significantly smaller than that utilized in classical definitions. Here, I exploit a sophisticated power stability mannequin to indicate that such an HZ could be significantly wider than initially predicted given revised CO2 limits and (for the primary time) N2 respiration limits for advanced life.

The width of this advanced life HZ (CLHZ) will increase by ~35% from ~0.95-1.2 AU to 0.95-1.31 AU in our photo voltaic system. Similar extensions are proven for stars with stellar efficient temperatures between 2,600-9,000 Okay. I outline this CLHZ utilizing lipid solubility principle, diving knowledge, and outcomes from animal laboratory experiments. I additionally focus on implications for biosignatures and technosignatures. Finally, I focus on the applicability of the CLHZ and different HZ variants to the seek for each easy and sophisticated life.

Evolution of Microbial Growth Traits Under Serial Dilution

Selection of mutants in a microbial inhabitants depends upon a number of mobile traits. In serial-dilution evolution experiments, three key traits are the lag time when transitioning from hunger to development, the exponential development price, and the yield (variety of cells per unit useful resource). 

Here we examine how these traits evolve in laboratory evolution experiments utilizing a minimal mannequin of inhabitants dynamics, the place the one interplay between cells is competitors for a single limiting useful resource.

We discover that the fixation chance of a useful mutation depends upon a linear mixture of its development price and lag time relative to its speedy ancestor, even below clonal interference. The relative selective strain on development price and lag time is ready by the dilution issue; a bigger dilution issue favors the difference of development price over the difference of lag time.

The mannequin exhibits that yield, nonetheless, is below no direct choice. We additionally present how the difference speeds of development and lag rely on experimental parameters and the underlying provide of mutations.

Finally, we examine the evolution of covariation between these traits throughout populations, which reveals that the inhabitants development price and lag time can evolve a nonzero correlation even when mutations have uncorrelated results on the 2 traits. Altogether these outcomes present helpful steerage to future experiments on microbial evolution.

Zika Virus Isolation, Purification, and Titration

Zika virus (ZIKV) is a vital pathogen transmitted to people by the mosquito vector Aedes aegypti. ZIKV is ready to infect a number of tissues and organs and, importantly, has been related to microcephaly and central nervous system abnormalities in fetuses and new child infants of moms uncovered to ZIKV throughout being pregnant, in addition to neurological ailments resembling Guillain-Barré syndrome in adults.

Tright here is at the moment no vaccine or drug licensed to stop or deal with ZIKV infections. The use of ZIKV isolation in illness prognosis has been largely changed by new strategies. However, virus isolation continues to be thought of as a gold customary for the detection of ZIKV and is often carried out in analysis and reference laboratories for characterization, sequencing, and quite a lot of analysis experiments together with pathogenesis, drug susceptibility, and vaccine efficacy.

The experimental procedures offered right here describe the commonest strategies used for ZIKV isolation, propagation, purification, and quantification.